Nanomedicines Against Mitochondrial Dysfunction‐Induced Metabolic Diseases

Abstract Mitochondrial dysfunction is a common pathology for metabolic diseases such as obesity, diabetes, non‐alcoholic fatty liver disease, atherosclerosis, Alzheimer's disease (AD), and Parkinson's disease (PD). Nanomedicines provide a revolutionary strategy for mitochondrial function repair. The...

詳細記述

書誌詳細

主要な著者:	Ke Xu, Leyi Wang, Tao Lv, Chen Jin, Qiong Wu, Yongjie Zhou, Gang Xu, Zhenyu Duan, Kui Luo, Jiayin Yang
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2025-12-01
シリーズ:	Advanced Science
主題:	metabolic diseases mitochondrial dysfunction nanomedicine targeted delivery
オンライン･アクセス:	https://doi.org/10.1002/advs.202514522
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!